Cargando…
Cellular accumulation of the anticancer agent cisplatin: a review.
Acquired resistance to cisplatin (DDP) is a major clinical problem in the treatment of ovarian, testicular, and head and neck carcinomas; decreased accumulation of DDP is the most consistently observed alteration in resistant cells. It has been postulated that DDP enters the cell by passive diffusio...
Autores principales: | Gately, D. P., Howell, S. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968522/ https://www.ncbi.nlm.nih.gov/pubmed/8512802 |
Ejemplares similares
-
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153.
por: Gately, D. P., et al.
Publicado: (1996) -
Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin
por: Wenande, Emily, et al.
Publicado: (2018) -
Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.
por: Gately, D. P., et al.
Publicado: (1994) -
Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2019) -
Anticancer/Antiviral Agent Akt Inhibitor-IV Massively
Accumulates in Mitochondria and Potently Disrupts Cellular Bioenergetics
por: Meinig, J. Matthew, et al.
Publicado: (2014)